CYCLOPHOSPHAMIDE\DOXORUBICIN: 35 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
35
Total FAERS Reports
1 (2.9%)
Deaths Reported
11
Hospitalizations
35
As Primary/Secondary Suspect
1
Life-Threatening
First Report: 2009 · Latest Report: 20241008
What Are the Most Common CYCLOPHOSPHAMIDE\DOXORUBICIN Side Effects?
#1 Most Reported
Off label use
6 reports (17.1%)
#2 Most Reported
Asthenia
6 reports (17.1%)
#3 Most Reported
Therapy partial responder
5 reports (14.3%)
All CYCLOPHOSPHAMIDE\DOXORUBICIN Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Asthenia | 6 | 17.1% | 0 | 1 |
| Off label use | 6 | 17.1% | 0 | 2 |
| Alopecia | 5 | 14.3% | 0 | 0 |
| Therapy partial responder | 5 | 14.3% | 0 | 0 |
Who Reports CYCLOPHOSPHAMIDE\DOXORUBICIN Side Effects? Age & Gender Data
Gender: 87.2% female, 12.8% male. Average age: 48.1 years. Most reports from: PT. View detailed demographics →
Is CYCLOPHOSPHAMIDE\DOXORUBICIN Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2009 | 1 | 0 | 0 |
| 2014 | 1 | 0 | 0 |
| 2016 | 1 | 1 | 1 |
| 2018 | 1 | 0 | 1 |
| 2019 | 2 | 0 | 2 |
| 2020 | 1 | 0 | 1 |
| 2023 | 4 | 0 | 0 |
| 2024 | 2 | 0 | 1 |
What Is CYCLOPHOSPHAMIDE\DOXORUBICIN Used For?
| Indication | Reports |
|---|---|
| Triple negative breast cancer | 19 |
| Breast cancer | 9 |
Official FDA Label for CYCLOPHOSPHAMIDE\DOXORUBICIN
Official prescribing information from the FDA-approved drug label.